Browsing by Author "Van Cutsem, Eric"
Now showing items 1-10 of 10
-
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
Tabernero Caturla, Josep; Grothey, Axel; Van Cutsem, Eric; Yaeger, Rona; Wasan, Harpreet; Yoshino, Takayuki (American Society of Clinical Oncology, 2021-02-01) -
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements
Bekaii-Saab, Tanios S; Valle, Juan W; Van Cutsem, Eric; Rimassa, Lorenza; Furuse, Junji; Ioka, Tatsuya; Macarulla Mercadé, Teresa (Future Medicine, 2020-10) -
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study
Tempero, Margaret A.; Oh, Do-Youn; Tabernero Caturla, Josep; Reni, Michele; Van Cutsem, Eric; Hendifar, Andrew E.; Macarulla Mercadé, Teresa (Elsevier, 2021-05) -
KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma
Tabernero Caturla, Josep; Bang, Yung-Jue; Van Cutsem, Eric; Fuchs, Charles; Janjigian, Yelena Yuriy; Bhagia, Pooja (Future Medicine, 2021-08) -
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Golan, Talia; Hammel, Pascal; Reni, Michele; Van Cutsem, Eric; Macarulla Mercadé, Teresa; Hall, Michael J (Massachusetts Medical Society, 2019-06-02) -
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study
Tabernero Caturla, Josep; Velez, L; Trevino, T. L.; Grothey, Axel; Yaeger, Rona; Van Cutsem, Eric (Elsevier, 2021-12) -
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164
Le, Dung T.; Kim, Tae Won; Van Cutsem, Eric; Geva, Ravit; Jäger, Dirk; Hara, Hiroki; Elez Fernandez, Mª Elena (American Society of Clinical Oncology, 2020-01-01) -
Quality of life with first-line pembrolizumab for PD-L1–positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study
Van Cutsem, Eric; Valderrama, A.; Bang, Yung-Jue; Fuchs, Charles; Shitara, Kohei; Janjigian, Yelena Yuriy; Alsina Maqueda, Maria (Elsevier, 2021-08) -
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
Van Cutsem, Eric; Tempero, Margaret A.; Sigal, Darren; Oh, Do-Youn; Fazio, Nicola; Macarulla Mercadé, Teresa (American Society of Clinical Oncology, 2020-09-20) -
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study
Tabernero Caturla, Josep; Shitara, Kohei; Zaanan, Aziz; Doi, Toshihiko; Lorenzen, S.; Van Cutsem, Eric; Alsina Maqueda, Maria (Elsevier, 2021-08)